Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
BPC-157 Upregulates VEGF and FGF in damaged tissue; accelerates wound closure and reduces inflammatory cytokine duration IL-6 reduced 50% within 72 hours in soft tissue models Localized soft tissue injuries: tendons, ligaments, m…
Thymosin Alpha-1 Immune modulation (Treg upregulation, cytokine normalization) 1.6mg subcutaneous, twice weekly for 12+ weeks 18-point FIQ reduction vs 4-point placebo in pilot trial; reduced IL-6 and TNF-alpha Subcutaneous injec…
Before reviewing individual peptides, understand that clinical response correlates with dysfunction subtype. No single peptide works universally. The table below ranks peptides by published efficacy, mechanism, tolerability, and …
Before selecting a peptide protocol, understand how mechanism, onset, and persistence differ across the three primary compounds used for periorbital wrinkle reduction. Each targets a distinct biological pathway. Choosing the righ…
BPC-157 VEGF upregulation, angiogenesis, fibroblast migration to ulcer site 250–500mcg SC twice daily (investigational human); 10–100mcg/kg in animal studies 48–72 hours for measurable vascular changes; 7–14 days for gross mucosa…
Survodutide (GLP-1/Glucagon) Incretin receptor agonism + hepatic fat oxidation High. Glucagon receptors densely expressed in visceral adipocytes 15.7% body weight reduction, 18.2% visceral fat reduction (Phase 2, The Lancet) ~5 d…
The table below compares mechanisms, clinical evidence, dosing protocols, and administration for the peptides most studied in menopause-related metabolic dysfunction. CJC-1295 + Ipamorelin GHRH analog + ghrelin mimetic; stimulate…
Research-grade peptides used in clinical trials differ from consumer products in three critical ways: purity, concentration, and vehicle formulation. Laboratory-grade peptides are synthesised to 98–99% purity with verified amino-…
Before selecting a peptide for endurance protocols, understand that each compound targets a different physiological bottleneck. The table below maps the best peptides to increase endurance ranked by mechanism, ideal exercise dura…
KPV (Lysine-Proline-Valine) NF-κB inhibition; reduces pro-inflammatory cytokine transcription (TNF-α, IL-6, IL-8) Mast cell activation and neutrophil chemotaxis Inflammation Research 2019: 52% reduction in IL-6 secretion at 10μM …
Kojic Acid Dipeptide Tyrosinase inhibition via copper chelation 2–3% active peptide 34–47% melanin reduction over 12 weeks (Stanford study, 2023) Most direct tyrosinase inhibitor with proven clinical results. Requires stable form…
| Peptide | Mechanism | VAT Reduction Evidence | Half-Life | Administration | Appetite Impact | Professional Assessment ||—|—|—|—|—|—|| CJC-1295/Ipamorelin | GHRH analog + ghrelin agonist. Dual GH elevation | 12.4% VAT reduction …
The table below compares the most effective peptide protocols for body recomposition based on mechanism, dosing logistics, and expected outcomes over a 12-week cycle. CJC-1295/Ipamorelin GHRH/GHRP synergy. Pulsatile GH/IGF-1 elev…
The table below compares the primary sleep-modulating peptides by mechanism, dosing framework, cycle structure, and target sleep pathology. Each peptide addresses a distinct biological pathway driving insomnia. Selection depends …
The pharmaceutical landscape for anxiety management centers on three drug classes: benzodiazepines (GABA-A receptor agonists), SSRIs (serotonin reuptake inhibitors), and buspirone (5-HT1A partial agonist). Each carries distinct e…
The following table summarizes the primary peptides studied for gastrointestinal repair, their mechanisms, typical research administration routes, and evidence quality. BPC-157 VEGF upregulation, angiogenesis, tight junction stab…
Peptide efficacy for Lyme support depends on which immune dysfunction you're addressing—T-cell exhaustion, inflammatory cytokine dominance, NK cell suppression, or residual antimicrobial activity. Here's how the primary candidate…
Selank GABA-A potentiation via enkephalin metabolism; inhibits breakdown of endogenous enkephalins that enhance GABAergic inhibition Intranasal 30-45 minutes (acute); 7-14 days (full anxiolytic) 600-3000mcg daily, divided doses C…
The table below compares mechanism, dosage range from published studies, and primary phase of action for the most-studied peptides in wound healing research. BPC-157 VEGF upregulation, angiogenesis, fibroblast proliferation 10–20…
The table below compares the most researched peptides for cognitive clarity based on primary mechanism, bioavailability, research depth, and clinical context. Semax BDNF/NGF upregulation, neuroplasticity enhancement Intranasal, s…